Description: Researches and develops disease-modifying therapies for neurodegenerative diseases
Home Page: www.neurobopharma.com
NRBO Technical Analysis
200 Berkeley Street
Boston,
MA
02116
United States
Phone:
857-702-9600
Officers
Name | Title |
---|---|
Dr. Ben Gil Price M.D. | CEO & Pres |
Dr. Matthew Bardin BCPS, Pharm.D. | Sr. VP of Operations |
Mr. Frank Kondrad | VP of Corp. & Bus. Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.84 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2016-08-05 |
Fiscal Year End: | December |
Full Time Employees: | 5 |